pubmed-article:9561916 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:9561916 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
pubmed-article:9561916 | lifeskim:mentions | umls-concept:C0022688 | lld:lifeskim |
pubmed-article:9561916 | lifeskim:mentions | umls-concept:C0016320 | lld:lifeskim |
pubmed-article:9561916 | lifeskim:mentions | umls-concept:C1510438 | lld:lifeskim |
pubmed-article:9561916 | lifeskim:mentions | umls-concept:C0182400 | lld:lifeskim |
pubmed-article:9561916 | pubmed:issue | 1-2 | lld:pubmed |
pubmed-article:9561916 | pubmed:dateCreated | 1998-6-4 | lld:pubmed |
pubmed-article:9561916 | pubmed:abstractText | A non-radioisotopic method for assessment of human natural killer (NK) cell activity in peripheral blood mononuclear cells (PBMC) was established by labelling K562 erythroleukemia target cells with a fluorescent dye, rhodamine-123 (Rh-123). The labelling and assay conditions were determined for minimizing spontaneous release (SR). In order to investigate whether NK activity assessed by measuring Rh-123 release agrees with the activity determined by a 51Cr release assay, the NK activity of PBMC was measured simultaneously by both assay methods. Statistical analysis demonstrates that NK activities determined by Rh-123 release correlate well with those measured by 51Cr release. The Rh-123 release assay under the conditions determined was found to be applicable to measurement of the enhanced NK activity resulting from pretreatment of effector leukocytes with interferon-alpha. It is concluded that the Rh-123 release assay with use of K-562 labelled target cells is practical for the assessment of human NK activity in laboratories where use of radioisotopes is not permitted or undesirable. | lld:pubmed |
pubmed-article:9561916 | pubmed:language | eng | lld:pubmed |
pubmed-article:9561916 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9561916 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:9561916 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9561916 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9561916 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9561916 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9561916 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9561916 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:9561916 | pubmed:issn | 0882-0139 | lld:pubmed |
pubmed-article:9561916 | pubmed:author | pubmed-author:MuraokaSS | lld:pubmed |
pubmed-article:9561916 | pubmed:author | pubmed-author:LievW AWA | lld:pubmed |
pubmed-article:9561916 | pubmed:author | pubmed-author:IwaoMM | lld:pubmed |
pubmed-article:9561916 | pubmed:author | pubmed-author:KuraneII | lld:pubmed |
pubmed-article:9561916 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:9561916 | pubmed:volume | 27 | lld:pubmed |
pubmed-article:9561916 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:9561916 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:9561916 | pubmed:pagination | 31-45 | lld:pubmed |
pubmed-article:9561916 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
pubmed-article:9561916 | pubmed:meshHeading | pubmed-meshheading:9561916-... | lld:pubmed |
pubmed-article:9561916 | pubmed:meshHeading | pubmed-meshheading:9561916-... | lld:pubmed |
pubmed-article:9561916 | pubmed:meshHeading | pubmed-meshheading:9561916-... | lld:pubmed |
pubmed-article:9561916 | pubmed:meshHeading | pubmed-meshheading:9561916-... | lld:pubmed |
pubmed-article:9561916 | pubmed:meshHeading | pubmed-meshheading:9561916-... | lld:pubmed |
pubmed-article:9561916 | pubmed:meshHeading | pubmed-meshheading:9561916-... | lld:pubmed |
pubmed-article:9561916 | pubmed:meshHeading | pubmed-meshheading:9561916-... | lld:pubmed |
pubmed-article:9561916 | pubmed:meshHeading | pubmed-meshheading:9561916-... | lld:pubmed |
pubmed-article:9561916 | pubmed:meshHeading | pubmed-meshheading:9561916-... | lld:pubmed |
pubmed-article:9561916 | pubmed:meshHeading | pubmed-meshheading:9561916-... | lld:pubmed |
pubmed-article:9561916 | pubmed:meshHeading | pubmed-meshheading:9561916-... | lld:pubmed |
pubmed-article:9561916 | pubmed:articleTitle | A non-radioisotopic human natural killer cell assay using rhodamine-123 fluorescent dye as labelling probe. | lld:pubmed |
pubmed-article:9561916 | pubmed:affiliation | Fujimoto Pharmaceutical Corporation, Osaka, Japan. | lld:pubmed |
pubmed-article:9561916 | pubmed:publicationType | Journal Article | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9561916 | lld:pubmed |